NRC

NRC

USD

National Research Corporation Common Stock (Delaware)

$14.700+0.360 (2.510%)

Precio en Tiempo Real

Healthcare
Health Information Services
Estados Unidos

Gráfico de Precios

Loading Chart...

Métricas Clave

Métricas de Mercado
Fundamentos de la Empresa
Estadísticas de Negociación

Métricas de Mercado

Apertura

$14.340

Máximo

$14.775

Mínimo

$14.135

Volumen

0.01M

Fundamentos de la Empresa

Capitalización de Mercado

333.1M

Industria

Health Information Services

País

United States

Estadísticas de Negociación

Volumen Promedio

0.10M

Bolsa

NMS

Moneda

USD

Rango de 52 Semanas

Mínimo $9.755Actual $14.700Máximo $21.64

Informe de Análisis de IA

Última actualización: 3 nov 2025
Generado por IAFuente de Datos: Yahoo Finance, Bloomberg, SEC

NRC Stock Update: National Research Corp Shows Volatile Recovery Pattern

Price Movement Summary

  • Recent Close: $13.43 (Nov 3) after bouncing from $11.28 low (Oct 10)
  • 3-Month Range: $11.28 - $16.14 (-30% peak-to-trough)
  • Key Catalyst: October 28 surge (+16% on 273k volume - 2.7x average)

Breaking Down the Action

  1. August Strength Steady climb from $12.58 to $16.03 (27% gain) on average volume, peaking Sept 9.

  2. September Breakdown Sharp 31% collapse from $16.03 to $11.48 over six weeks, accelerated by high-volume selling Sept 19 (-6.9%) and Sept 29 (-6.2%).

  3. October Rebound October 28 explosion ($11.43→$13.25) marked strongest single-day gain since August. Subsequent consolidation between $12.62-$13.45 suggests new trading range forming.

Technical Positioning

  • Bullish Signals: MACD crossover + volume surge confirm momentum shift
  • Immediate Resistance: $13.45-13.62 area (recent highs & Bollinger upper band)
  • Critical Support: $12.02-12.62 zone (October rebound base)
  • Volume Profile: Sustained above-average trading since rebound (115k-141k vs 101k avg)

Fundamental Context

MetricValueImplication
ROE66.9%Exceptional capital efficiency
⚠️Debt/Equity559%Highly leveraged structure
🔻Revenue Growth-3.4%Contracting operations
📊P/E11.57Below healthcare sector average

Strategic Considerations

For Active Traders

  • Near-term upside to $13.62 (+1.4%) if momentum holds
  • Stop-loss prudent below $12.75 (recent consolidation low)
  • Watch for volume confirmation on breakout attempts

Longer-Term Investors

  • High debt load raises sustainability questions
  • Negative growth contrasts with strong ROE - warrants deeper due diligence
  • Sector outlook for health analytics remains favorable despite company-specific risks

Recommended Action Plan

  1. Day Traders: Scalp $13.15-13.45 range with tight stops
  2. Swing Traders: Consider long positions above $13.30 targeting $13.62 exit
  3. Risk-Averse Investors: Monitor debt management progress before entry

Data reflects market conditions as of November 3, 2025 closing. Past performance ≠ future results. Consult a financial advisor before trading. Volatility risk elevated with 52-week range of $9.76-$21.64.

Predicción de IABeta

Recomendación de IA

Neutral

Actualizado el: 10 nov 2025, 13:54

BajistaNeutralAlcista

65.2% Confianza

Riesgo y Negociación

Nivel de Riesgo4/5
Riesgo Alto
Adecuado Para
Moderado
Guía de Negociación

Punto de Entrada

$14.43

Toma de Ganancias

$15.02

Stop Loss

$13.26

Factores Clave

PDI 19.4 está por encima de MDI 8.9 con ADX 19.1, lo que sugiere una tendencia alcista
El precio actual está cerca del nivel de soporte ($14.49), lo que indica una posible oportunidad de compra
El volumen de operaciones es 2.3 veces el promedio (1,578), lo que muestra un interés significativo en la compra
El MACD 0.0541 está por encima de la línea de señal 0.0328, lo que indica un cruce alcista

Mantente Actualizado

Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.